About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Maryland | 345 Studies

Clinical Trials Pancreatic CancerMaryland

Pancreatic Cancer Clinical Trials in Maryland

Find 345 clinical trials for pancreatic cancer near Maryland. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 345 trials

TerminatedARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic CancerThis is a study of ARQ-761 (beta-lapachone) with gemcitabine/nab-paclitaxel chemotherapy in subjects with advanced (metastatic, unresectable, or recurrent) pancreatic cancer that…NCT02514031·Baltimore, Maryland and 1 other RecruitingBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)This is a study to evaluate the efficacy and safety of belzutifan monotherapy in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor…NCT04924075·Los Angeles, California and 84 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic AdenocarcinomaThe proposed study is an open-label, two-arm study of entinostat plus nivolumab in patients with unresectable or metastatic cholangiocarcinoma (CCA) or pancreatic ductal…NCT03250273·Baltimore, Maryland

CompletedStudy of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyStudy of NGM120 in subjects with advanced solid tumors and pancreatic cancer (Part 1 and 2) and metastatic castration resistant prostate cancer (Part 3).NCT04068896·Tucson, Arizona and 19 others

CompletedSafety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid TumorsTest the hypothesis that itacitinib (INCB039110) can be administered safely in combination with gemcitabine and nab-paclitaxel in subjects with advanced or metastatic cancer.NCT01858883·Scottsdale, Arizona and 7 others

RecruitingA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationThis study is conducted to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.NCT06179160·Phoenix, Arizona and 33 others

CompletedSirolimus in Treating Patients With Advanced Pancreatic CancerRATIONALE: Sirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00499486·Baltimore, Maryland

CompletedAdjuvant GVAX Vaccine Therapy in Patients With Pancreatic CancerThis is an open label, phase II trial study of adjuvant GVAX pancreas vaccine in patients with pancreatic cancer.NCT00389610·Baltimore, Maryland

TerminatedA Study of [225Ac]-FPI-2059 in Adult Participants With Solid TumoursThis is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of \[225Ac\]-FPI-2059 and…NCT05605522·Birmingham, Alabama and 7 others

TerminatedStudy of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentThis clinical trial will evaluate the safety and tolerability of CRS 207 an investigational product that is a weakened form (attenuated) of Listeria monocytogenes, a type of…NCT00585845·Baltimore, Maryland and 3 others

CompletedNatural History and Management of Pancreatic Lesions in Von Hippel-Lindau DiseaseVon Hippel-Lindau disease (VHL) is an inherited cancer syndrome. Patients are at risk for developing pancreatic cysts and tumors.NCT00062166·Bethesda, Maryland

CompletedGanitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the PancreasRATIONALE: Monoclonal antibodies, such as ganitumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT01298401·Orange, California and 9 others

Active not recruiting1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic AdenocarcinomaAssess the effectiveness of galeterone in advanced pancreatic adenocarcinomaNCT04098081·Baltimore, Maryland

CompletedCombination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00020345·Bethesda, Maryland and 1 other

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

TerminatedAbility of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous CancerBackground: Exomes are the parts of deoxyribonucleic acid (DNA) that make proteins. Researchers are finding a way to read the letters in the exome.NCT03300843·Bethesda, Maryland

Active not recruitingIntraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic AdenocarcinomaThis study is designed to investigate the safety of intraoperative radiation therapy (IORT) in patients with localized pancreatic cancer undergoing surgical resection after…NCT05141513·Baltimore, Maryland

CompletedA Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine TreatmentThe purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5…NCT04083235·Birmingham, Alabama and 199 others

CompletedA Study of BMS-986416 With and Without Nivolumab in Select Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, drug effects, drug levels and preliminary antitumor activity of BMS-986416 when administered alone and in…NCT04943900·Atlanta, Georgia and 18 others

RecruitingAdministering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsBackground: A new cancer therapy involves taking white blood cells from a person, growing them in the lab, genetically modifying them, then giving them back to the person.NCT03190941·Bethesda, Maryland

PreviousPage 9 of 18Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia